Shattuck Labs, Inc. (NASDAQ:STTK) shares are volatile in Wednesday’s session after the company announced the pricing of a public offering of its common stock.
The offering is expected to generate approximately $75 million before deducting underwriting discounts and commissions, which may impact investor sentiment.
Shattuck Labs Public Offering
Shattuck Labs has priced its public offering at $4.00 per share for 10,879,376 shares, along with pre-funded warrants at $3.9999 per warrant.
The offering is anticipated to close on June 11, 2026, subject to customary closing conditions.
Shattuck Labs is a clinical-stage biotechnology company focused on developing monoclonal and bispecific DR3-blocking antibodies, including potential first-in-class therapies, for inflammatory and immune-mediated diseases.
STTK Technical Analysis
From a longer-term trend lens, STTK is still holding just above its 200-day SMA at $4.01, but it’s trading 22.2% below its 20-day SMA ($5.67) and 32% below its 50-day SMA ($6.49), which keeps the intermediate trend pointed down.
The 20-day SMA sitting below the 50-day SMA adds to that bearish near-term structure, even though the stock remains up 280.17% over the past 12 months.
Momentum is the bigger story right now: RSI is 28.23, which puts the stock in oversold territory and suggests selling pressure has become stretched.
RSI is a speedometer for recent price moves—readings this low often coincide with “capitulation-style” selling where bounces can start, but it doesn’t guarantee a bottom without follow-through.
- Key Resistance: $5.00 — a round-number area that also sits below the cluster of short- and medium-term moving averages, where rebounds can stall
Shattuck Labs Price Action
STTK Stock Price Activity: Shattuck Labs shares were trading up 6.79% at $4.560 at the time of publication on Wednesday, according to Benzinga Pro data.
Phot via Shutterstock
